News Vical slashes staff after culling phase II antifungal Phil Taylor antifungal, Vical 0 Comment US biotech Vical is planning another round of job cuts after deciding to abandon its antifungal drug VL-2397, Share X Vical slashes staff after culling phase II antifungal https://pharmaphorum.com/news/vical-staff-culling-phase-ii-antifungal/
